Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 4,747 | 4,828 | 5,158 | 7,004 | 3,531 |
| Operating Income | -4,747 | -4,828 | -5,158 | -7,004 | -3,531 |
| Other Income | -39 | -4 | -39 | -35 | -7 |
| Pre-tax Income | -4,786 | -4,832 | -5,197 | -7,039 | -3,538 |
| Net Income Continuous | -4,786 | -4,832 | -5,197 | -7,039 | -3,538 |
| Net Income | $-4,786 | $-4,832 | $-5,197 | $-7,039 | $-3,538 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| EBITDA(a) | $-4,745 | $-4,826 | $-5,152 | $-6,998 | $-3,522 |